Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene.

J Formos Med Assoc

Liver Unit, Cathay General Hospital, Taipei, Taiwan; Medical Faculty, Fu-Jen Catholic University, Taipei, Taiwan. Electronic address:

Published: November 2015

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jfma.2014.11.004	DOI Listing

Publication Analysis

interferon ribavirin

ribavirin combination

combination therapy

therapy linked

linked severe

severe indirect

indirect hyperbilirubinemia

hyperbilirubinemia patients

patients nt-211g

nt-211g variant

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!